A discussion of the growing links between the issues of globalisation, health and foreign policy. This article examines the effect this has on health, development and foreign policy communities in the UK and internationally and considers what steps the policy community must take to address the challenges and opportunities of this new relationship.

The NHS spends £20 billion on procuring a wide range of medical goods every year. Worldwide, the amount traded in products for health care runs into trillions of dollars. With such large sums of money we quite rightly ask about value for money as well as the quality of the goods we buy. But in addition to quality we should, but don't, ask about the conditions under which those goods are made. Unfortunately, recent research has found that some of the products we are using to promote health in the UK may actually be damaging health elsewhere, through unethical labour practices in their manufacture.

Initial success of UK government strategies in Malawi must be sustained